These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2609332)

  • 1. Identification of benzoylcarnitine in the urine of a patient of hyperammonemia.
    Sakuma T; Asai K; Ichiki T; Sugiyama N; Kidouchi K; Wada Y
    Tohoku J Exp Med; 1989 Oct; 159(2):147-51. PubMed ID: 2609332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of urinary carnitine profile induced by benzoate administration.
    Sakuma T
    Arch Dis Child; 1991 Jul; 66(7):873-5. PubMed ID: 1863104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urinary levels of carnitine in different experimental models of hyperammonemia and the effect of sodium benzoate treatment.
    Michalak A; Qureshi IA
    Biochem Med Metab Biol; 1990 Apr; 43(2):163-74. PubMed ID: 2346672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of carbamylphosphate synthetase-I deficiency associated with secondary carnitine deficiency--L-carnitine treatment of CPS-I deficiency.
    Mori T; Tsuchiyama A; Nagai K; Nagao M; Oyanagi K; Tsugawa S
    Eur J Pediatr; 1990 Jan; 149(4):272-4. PubMed ID: 2303075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of severe carbamyl phosphate synthetase I deficiency.
    Van de Bor M; Mooy P; van Zoeren D; Berger R; van Gelderen HH; Teijema HL
    Arch Dis Child; 1984 Dec; 59(12):1183-5. PubMed ID: 6524951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Carbamyl phosphate synthase deficiency: clinical symptoms, diagnosis and dietary-medicamentous treatment in the neonatal period and infancy].
    Hochreutener H; Issakainen J; Bachmann C; Baerlocher K
    Helv Paediatr Acta; 1989 Jun; 43(5-6):493-505. PubMed ID: 2745145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal.
    Feoli-Fonseca JC; Lambert M; Mitchell G; Melançon SB; Dallaire L; Millington DS; Qureshi IA
    Biochem Mol Med; 1996 Feb; 57(1):31-6. PubMed ID: 8812724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
    Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
    N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of long-term administration of sodium benzoate to a patient with partial ornithine carbamoyl transferase deficiency.
    Takeda E; Kuroda Y; Toshima K; Watanabe T; Naito E; Miyao M
    Clin Pediatr (Phila); 1983 Mar; 22(3):206-8. PubMed ID: 6825366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective versus clinical diagnosis and therapy of acute neonatal hyperammonaemia in two sisters with carbamyl phosphate synthetase deficiency.
    Tuchman M; Mauer SM; Holzknecht RA; Summar ML; Vnencak-Jones CL
    J Inherit Metab Dis; 1992; 15(2):269-77. PubMed ID: 1356172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Carnitine levels in muscle in mice with hyperammonemia: effect of treatment with sodium benzoate].
    Michalak A; Qureshi IA
    Can J Physiol Pharmacol; 1993 Jul; 71(7):439-46. PubMed ID: 8242478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potentiation of ammonia toxicity by sodium benzoate is prevented by L-carnitine.
    O'Connor JE; Costell M; Grisolía S
    Biochem Biophys Res Commun; 1987 Jun; 145(2):817-24. PubMed ID: 3593373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypocarnitinemia in patients affected by a primary defect of ammonia metabolism treated with sodium benzoate].
    Michalak A; Lambert MA; Dallaire L; Melançon SB; Laframboise R; Lemieux B; Qureshi IA
    Diabete Metab; 1990; 16(3):226-33. PubMed ID: 2210018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
    Michalak A; Qureshi IA
    Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
    Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
    Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperammonemia related to carnitine metabolism with particular emphasis on ornithine transcarbamylase deficiency.
    Matsuda I; Ohtani Y; Ohyanagi K; Yamamoto S
    Enzyme; 1987; 38(1-4):251-5. PubMed ID: 3440448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid acylation: a mechanism of nitrogen excretion in inborn errors of urea synthesis.
    Brusilow S; Tinker J; Batshaw ML
    Science; 1980 Feb; 207(4431):659-61. PubMed ID: 6243418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial urea cycle enzymes in rats treated with sodium benzoate.
    Colombo JP; Bachmann C; Pfister U; Gradwohl M
    Biochem Biophys Res Commun; 1988 Mar; 151(2):872-7. PubMed ID: 3348818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue acylcarnitine and acyl-coenzyme A profiles in chronically hyperammonemic mice treated with sodium benzoate and supplementary L-carnitine.
    Michalak A; Qureshi IA
    Biomed Pharmacother; 1995; 49(7-8):350-7. PubMed ID: 8562862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.